Abstract |
The role of human immunodeficiency virus type 1 (HIV-1) infection on the ability of human monocytes/macrophages to phagocytose Mycobacterium avium complex (MAC) in vivo and in vitro and the effect of granulocyte-macrophage colony-stimulating factor ( GM-CSF) on this function were investigated. By use of a flow cytometric assay to quantify phagocytosis, HIV-1 infection was found to impair the ability of monocyte-derived macrophages to phagocytose MAC in vitro, whereas GM-CSF significantly improved this defect. Phagocytosis was not altered by exposure to a mutant form of GM-CSF (E21R) binding only to the alpha chain of the GM-CSF receptor, suggesting that signaling by GM-CSF that leads to augmentation of phagocytosis is via the beta chain of the receptor. In a patient with AIDS and disseminated multidrug-resistant MAC infection, GM-CSF treatment improved phagocytosis of MAC by peripheral blood monocytes and reduced bacteremia. These results imply that GM-CSF therapy may be useful in restoring antimycobacterial function by human monocytes/macrophages.
|
Authors | K Kedzierska, J Mak, A Mijch, I Cooke, M Rainbird, S Roberts, G Paukovics, D Jolley, A Lopez, S M Crowe |
Journal | The Journal of infectious diseases
(J Infect Dis)
Vol. 181
Issue 1
Pg. 390-4
(Jan 2000)
ISSN: 0022-1899 [Print] United States |
PMID | 10608795
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Granulocyte-Macrophage Colony-Stimulating Factor
|
Topics |
- Adult
- Cells, Cultured
- Granulocyte-Macrophage Colony-Stimulating Factor
(pharmacology, therapeutic use)
- HIV Infections
(complications)
- HIV-1
(growth & development)
- Humans
- Macrophages
(drug effects, microbiology, virology)
- Male
- Monocytes
(drug effects, microbiology, virology)
- Mycobacterium avium Complex
(immunology)
- Mycobacterium avium-intracellulare Infection
(complications, drug therapy)
- Phagocytosis
(drug effects)
|